Area of research
General Health Professions · Hematology
Research interest
Research interests include Medicine, Oncology, Myelodysplastic syndromes, Cancer research, Lenalidomide, and Venetoclax.
Ixazomib maintenance therapy in transplant-eligible multiple myeloma: real-world evidence from three large German centers
Venetoclax with azacitidine targets refractory MDS but spares healthy hematopoiesis at tailored dose
Inhibition of PLK1 by capped‐dose volasertib exerts substantial efficacy in MDS and sAML while sparing healthy haematopoiesis
Biomodulatory therapy approach with lenalidomide in combination with pioglitazone, dexamethasone, and metronomic low-dose chemotherapy with treosulfan in patients with relapsed/refractory multiple myeloma > second-line.
Selective inhibition of BCL-2 is a promising target in patients with high-risk myelodysplastic syndromes and adverse mutational profile
Lenalidomide with Low-Dose Dexamethasone (Rd) Continuously Versus Rd Induction, Tandem MEL140 with Autologous Transplantation and Lenalidomide Maintenance: Planned Interim Analysis of a Prospective Randomized Trial in Patients 60-75 Years of Age with Multiple Myeloma